ENTITY
Giant Biogene

Giant Biogene (2367 HK)

140
Analysis
Consumer StaplesChina
Giant Biogene Holding Co., Ltd researches, develops, manufactures, and distributes, and markets skin treatment products. The Company produces recombinant collagen and rare ginsenosides skin treatment products, functional foods, and other products. Giant Biogene Holding conducts businesses in China.
more
26 Jun 2025 07:32

Eternal Beauty IPO Trading - Weak Demand, Close to Fair Value

Eternal Beauty Holdings raised around US$125m in its Hong Kong IPO after pricing its IPO near the low-end. In this note, we talk about the trading...

Logo
480 Views
Share
18 Jun 2025 14:16

Eternal Beauty IPO - Not Expensive but Its Not Enticing Either

Eternal Beauty Holdings Limited is looking to raise around US$144m in its Hong Kong IPO. We have looked at the past performance in our earlier...

Logo
591 Views
Share
12 Jun 2025 10:34

Eternal Beauty Pre-IPO - PHIP Updates - Perfumes Growing, Challenges Remain

Eternal Beauty Holdings (EB) is looking to raise around US$150m in its upcoming Hong Kong IPO. In this note, we look at the updates from its PHIP.

Logo
580 Views
Share
10 Jun 2025 13:41

Eternal Beauty Pre-IPO - The Positives - Expanding Its Brands and Offering

Eternal Beauty is now looking to raise around US$150m in its Hong Kong IPO. We have looked at the past performance earlier.

Logo
606 Views
Share
08 Jun 2025 09:13

China Healthcare Weekly (Jun.8)-Summit/Akeso, Giant Biogene's Trouble, Views on Newtrend IPO Pricing

​Summit's chances of being sold decrease largely, so the outlook of Summit/Akeso is passive. Doubts raised about Giant Biogene's outlook after Zhao...

Logo
490 Views
Share
x